`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`PROTECTIVE ORDER MATERIAL
`
`47
`
`Page 61 0' 132
`
`EDWARDS 01809211
`
`
`
`Page 62 of 132
`
`Edwards Lifesciences v. Boston Scientific Scimed
` IPR2017-00060 U.S. Patent 8,992,608
` Exhibit 2057 - Part 14
` PROTECTIVE ORDER MATERIAL
`
`
`
`
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 u.s. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`PROTECTIVE ORDER MATERIAL
`
`48
`
`Page 63 0' 132
`
`EDWARDS 01809213
`
`
`
`Marketing strategy to drive commercial demand and
`establish premium market position
`
`
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`PROTECTIVE ORDER MATERIAL
`
`lzcl“ urtl~
`
`Page 54 0’ 132
`
`EDWARDS 01809214
`
`
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`PROTECTIVE ORDER MATERIAL
`
`49
`
`Page 65 0' 132
`
`EDWARDS 01809215
`
`
`
`
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`lzcl“ urr|~
`
`Page 5‘5 01‘1”
`
`EDWARDS 01809216
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`
`
`
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 u.s. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`PROTECTIVE ORDER MATERIAL
`
`50
`
`Page 67 0' 132
`
`EDWARDS 01809217
`
`
`
`
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`lzcl“ urr|~
`
`Page ‘58 °f132
`
`EDWARDS 01809218
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`
`
`Seven successful live cases 2H 2012- 1H 201:
`
`leuro
`
`KR The leading
`
`cardiovascular Course
`
`German Annual Users Mt
`
`TV‘I’
`
`lfnscathe(tTe\r/\T/;alzv:13
`
`erapies
`
`
`
`M Thomas : “Edwards
`has eliminated PVL from
`TAVI”
`
`T. Walther: First 15
`patients, and I can’t
`see any leaks
`
`J Webb: Virtually no
`leak to speak of
`J Ye: 15 mins to
`deploy and no leak
`
`—|l“!-
`
`Highly Confidential
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`PROTECTIVE ORDER MATERIAL
`
`Page 59 °f ‘32
`
`EDWARDS 01809219
`
`
`
`
`
`Edwards Lifesciences v. Boston Scientific Scimed
`
`lzcl“ urr|~
`
`Page 7° °f132
`
`EDWARDS 01809220
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`IPR2017-00060 U.S. Patent 8,992,608
`Exhibit 2057 - Part 14
`
`